2 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Practice Guidelines as Topic: new trials by email Literature Review of Practice Guidelines as Topic trials Research Report on Practice Guidelines as Topic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors Best Practice, Entecavir, Tenofovir Alafenamide - Hepatitis B Infection, Malignant Solid Neoplasm | Phase 3 | Terminated | SWOG Cancer Research Network | 4 | 2020-01-17 | 2024-05-20 |
| Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases Supportive Palliative Care, Clinical Management, Best Practice - Hematopoietic and Lymphoid Cell Neoplasm, Non-Neoplastic Hematologic and Lymphocytic Disorder | Phase 2 / Phase 3 | Terminated | Fred Hutchinson Cancer Center | 458 | 2019-08-15 | 2026-01-12 |
Hematologic Neoplasms (1) · Hepatitis B (1)
Fred Hutchinson Cancer Center (1) · SWOG Cancer Research Network (1)
United States (2) · Guam (1)
Jessica P Hwang (1) · Mohamed Sorror, MD, MSc (1)
R01CA227092 (1), UG1CA189974 (1)